OTC GERD aids
This article was originally published in The Tan Sheet
Executive SummaryOTC medications "have a clinically meaningful role in treating" gastroesophageal reflux disease and provide "rapid, effective and safe relief" of episodic heartburn for periods not exceeding four weeks, an 1American Gastroenterological Association consensus panel report says. In treatment guidelines released Nov. 14, AGA panel concludes 60%-70% of patients studied in randomized clinical trials responded to acid neutralization or acid inhibition by OTC medications, such as antacids, H2 antagonists and H2/antacid combinations. Citing data from J&J/Merck's FACT study of 1,640 patients who were randomly assigned the H2/antacid combination Pepcid Complete, famotidine alone, antacid alone or placebo, AGA panel asserts H2/antacid combination "provides an incremental improvement in efficacy, compared with the individual agents." J&J/Merck provided an unrestricted educational grant for the AGA panel's work...
You may also be interested in...
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.
Laparoscopic power morcellation to remove uterine fibroids should only be performed with the use of a compatible containment system, and only on women younger than 50, the US FDA said in a newly published safety communication and draft guidance document. See what the president of the gynecologic trade group AAGL, Jubilee Brown, said about it here.